Dana Farber Cancer Institute/Pharmacy — Boston, Massachusetts

Dana Farber Cancer Institute/Pharmacy is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute/Pharmacy has participated in 2 clinical trials.

Therapeutic areas: Non Small Cell Lung Cancer ALK Positive or ROS1 Positive, Carcinoma, Non-Small-Cell Lung.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute/Pharmacy?

Dana Farber Cancer Institute/Pharmacy has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute/Pharmacy conducted?

Dana Farber Cancer Institute/Pharmacy has 2 clinical trials on record. Their work covers Non Small Cell Lung Cancer ALK Positive or ROS1 Positive, Carcinoma, Non-Small-Cell Lung.

Is Dana Farber Cancer Institute/Pharmacy accredited by Crixeo Clinical Trials?

Dana Farber Cancer Institute/Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute/Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.